Document Type
Original Study
Abstract
Purpose: The goal of this study was to evaluate the clinical effect of topically controlled release simvastatin with dental implant in type II diabetic patients. Materials and Methods: Sixteen diabetic type II patients with missing teeth were selected according to inclusion and exclusion criteria. Patients were divided randomly into two groups using flip coin method. Group I (test group): 8 patients underwent implant placement for missed tooth with controlled released simvastatin around the implant. Group II (control Group): 8 patients underwent implant placement for missed tooth without controlled released simvastatin around the implant. All patients were followed up clinically and radio-graphically for 6 months postoperatively after implant placement. Results: The use of Simvastatin controlled release gel with delayed dental implants decrease postoperative pain and swelling Conclusion: This research showed that the drug delivery system of controlled release simvastatin improve the repair and healing of bone and soft tissue around dental implant in diabetic type II patients
Keywords
Dental implant, Diabetes type II, Simvastatin
How to Cite This Article
Baheir, Salma M.; Attia, Mai S.; and Dawaba, Aya M.
(2023)
"Evaluation of Controlled Release Simvastatin around Dental Implant in Controlled Type II Diabetic Patient,"
Al-Azhar Journal of Dentistry: Vol. 10:
Iss.
1, Article 33.
DOI: https://doi.org/10.58675/2974-4164.1541
Subject Area
Oral Medicine and Surgical Sciences Issue (Oral Medicine, Oral and Maxillofacial Surgery, Oral Pathology, Oral Biology)